🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Labroplasty in Cases of Anterior Shoulder Instability With Subcritical Glenoid Bone Loss

RecruitingNAAges 16 Years - anyAllKasr El Aini Hospital
NCT07488039 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to learn Labroplasty using the long head of biceps tendon works to patients with recurrent anterior shoulder instability with subcritical glenoid bone loss (\<20%) and thinned or deficient anterior labrum .The main questions it aims to answer are: Does Labroplasty using the long head of biceps improve the functional and radiological outcomes in patients with recurrent anterior shoulder instability with subcritical glenoid bone loss? Participants will: undergo arthroscopic labroplasty using the long head of biceps tendon Visit the clinic regularly for checkup and followup undergo MRI at 6 months to check radiological outcome

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * patients with recurrent anterior shoulder instability with one or more events of anterior shoulder dislocation. * Franceschi types 2 and 3 labral defects * subcritical glenoid bone loss \<20% * positive anterior shoulder apprehension Exclusion Criteria: * Critical glenoid bones loss \>20% * Franceschi type 1 labral defect * concomitant long head of biceps tendon pathology * multidirectional instability * prior arthroscopic shoulder stabilization surgery * concomitant proximal humeral fractures * concomitant Rotator cuff tears * skeletally immature patients * glenoid pathology * Shoulder arthritis * active infection
💊

What it tests

  • Arthroscopic Labroplasty using long head of biceps tendon
📍

Where

1 site
Kasr El Aini Hospital
Cairo, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy